Laboratory Corporation

Red Flags in the Boardroom - BusinessWeek

How to tell if your company is taking on too much risk The aftermath of the corporate meltdowns at Lehman Brothers, AIG, Merrill Lynch, and others has left board members in all sectors—not just financial services—asking...

LabCorp ends sale of ovarian cancer test

LabCorp ends sale of ovarian cancer test BURLINGTON - Laboratory Corporation of America has stopped selling an ovarian cancer screening test that received Food and Drug Administration scrutiny after a loophole allowed it to be...

Selective Testing by Alexander Gelfand

Does Big Pharma stand to gain the most from new genetic tests for drug therapy? It’s a mild June day in New York, and Mark Milano, a fit fifty-two-year-old ... Continue reading this article at http://www.walrusmagazine.com

Examine the DNA Diagnostics: Technologies and Global Markets

Examine the DNA Diagnostics: Technologies and Global MarketsNEW YORKNY-REPORTLINKER NEW YORK--(BUSINESS WIRE)-- INTRODUCTION STUDY GOALS AND OBJECTIVES REASONS FOR DOING THE STUDY SCOPE OF REPORT INTENDED AUDIENCE METHODOLOGY...

LabCorp is Scheduled to Present at the Credit Suisse 2008 Global Healthcare Conference

Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that William B. (Brad) Hayes, Executive Vice President and Chief Financial Officer, is scheduled to speak at the.. - Read more

LabCorp to be the First National Commercial Lab to Offer Roche's COBAS(R) TaqMan(R)

LabCorp to be the First National Commercial Lab to Offer Roche's COBAS(R) TaqMan(R) HBV Test BURLINGTON, N.C.--(Business Wire)-- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) announces that it will be...

ARCA biopharma to Present at Rodman & Renshaw Tenth Annual Healthcare Conference

BROOMFIELD, Colo. and SAN CARLOS, Calif., Nov. 6 /PRNewswire-FirstCall/ -- ARCA biopharma, Inc., a biopharmaceutical company developing genetically-targeted therapies for heart failure and other cardiovascular diseases, and...

EXACT Sciences Corporation to Present at the Rodman & Renshaw 10th Annual Healthcare Conference

Posted on: Wednesday, 5 November 2008, 18:00 CST EXACT Sciences Corporation (NASDAQ: EXAS) announced today that it is scheduled to present at the Rodman & Renshaw 10th Annual Health Care Conference on Wednesday, November 12,...

Mubadala Healthcare and Laboratory Corporation of America Holdings Agree to Establish a National...

News source: Business Wire Mubadala Healthcare, the specialist division of Mubadala Development Company, and Laboratory Corporation of America Holdings, more commonly known as LabCorp , today announced their agreement to...

LabCorp presents positive results on GST-Pi/APC methylation test for detection of prostate cancer

LabCorp presents positive results on GST-Pi/APC methylation test for detection of prostate cancer - OncoMethylome's methylation technology for improving the detection of prostate cancer was validated i... [WebWire - Tuesday,...

1 2 next